The effect of tranexamic acid on hidden blood loss in total hip arthroplasty

dc.authorid0000-0001-8873-1358
dc.authorid0000-0003-1525-9966
dc.authorid0000-0002-6294-4838
dc.authorid0000-0003-0331-9044
dc.authorid0000-0002-8685-2356
dc.authorid0000-0002-8139-8780
dc.contributor.authorAktı, Sefa
dc.contributor.authorZeybek, Hakan
dc.contributor.authorBilekli, Ahmet Burak
dc.contributor.authorÇelebi, Nilgün Özgül
dc.contributor.authorErdem, Yusuf
dc.contributor.authorÇankaya, Deniz
dc.date.accessioned2022-05-12T11:56:19Z
dc.date.available2022-05-12T11:56:19Z
dc.date.issued2022
dc.departmentTıp Fakültesi
dc.description.abstractObjectives: In this study, we aimed to examine the effect of tranexamic acid (TXA) on hidden blood loss in total hip arthroplasty (THA) patients. Patients and methods: Between June 2015 and June 2021, a total of 120 patients (45 males, 75 females; mean age 57.2±4.9 years; range, 45 to 67 years) with primary osteoarthritis who underwent THA without the use of TXA and 53 patients who received TXA were retrospectively analyzed. Demographic data, amount of transfusion, early complications, preoperative and postoperative hemoglobin and hematocrit values, total blood loss, visible blood loss, and hidden blood loss values were compared. Results: There was a significant difference between the groups with and without the use of TXA in terms of intraoperative bleeding, amount of blood in the drain, total blood loss, hidden blood loss, and blood transfusion (p<0.05). A significant positive correlation was found between intraoperative blood loss and hidden blood loss (r=0.325 p<0.01), while no significant correlation was found between postoperative drainage volume and hidden blood loss (r=-0.006 p=0.946). Conclusion: The use of TXA in patients undergoing THA reduces blood loss, including hidden blood loss, thereby reducing the need for blood transfusion after hip arthroplasty. However, there seems to be no linear relationship between postoperative blood loss and hidden blood loss. Considering these results, the routine use of TXA can be recommended in THA, unless there is a contraindication.
dc.identifier.doi10.52312/jdrs.2022.446
dc.identifier.endpage108en_US
dc.identifier.issn2687-4784
dc.identifier.issue1en_US
dc.identifier.pmid35361084
dc.identifier.scopusqualityQ2
dc.identifier.startpage102en_US
dc.identifier.urihttps:/dx.doi.org/10.52312/jdrs.2022.446
dc.identifier.urihttps://hdl.handle.net/20.500.12451/9380
dc.identifier.volume33en_US
dc.identifier.wosWOS:000778960800012
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTurkish Joint Diseases Foundation
dc.relation.ispartofJoint Diseases and Related Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHidden Blood Loss
dc.subjectTotal Hip Arthroplasty
dc.subjectTranexamic Acid
dc.titleThe effect of tranexamic acid on hidden blood loss in total hip arthroplasty
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
akti-sefa-2022.pdf
Boyut:
281.61 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: